The safety of novel foods must be assessed before they are placed on the market within the European Union or USA. The application submitted to the regulatory agencies must include description and detailed composition of the novel food, the production process, and scientific evidence demonstrating that the novel food does not pose safety risk to human health. BaseClear provides support at all steps in the process, whether early-stage research or seeking approval for an already developed novel food.
Microorganisms can only be applied as a food ingredient or production strain if they are sufficiently stable and able to function optimally under the desired conditions. Probiotic bacteria, for example, often need to be able to withstand the gastric acid and bile salts that are present in the stomach and intestines. To investigate and optimize these characteristics, it is necessary to find out which genes are expressed in a given physiological background.
BaseClear offers expert services in particular for food consisting of, isolated from or produced from microorganism (bacteria, fungi or algae) and food consisting of, isolated from or produced from cell culture or tissue culture. We have extensive experience and several PhD-level scientists ready to help in assessing the food microbe safety of the products.
Food enzymes used in human nutrition are generally produced by microorganisms. Safety must be assessed before the enzymes can be offered to the market. The application submitted to the regulatory...
For nutrition or health claims, the Food Safety Authority (EFSA or FDA) requires full knowledge of the organism you are working with. BaseClear can facilitate this with a complete solution including...
BaseClear can help you acquire a safety assessment dossier on microorganisms used as production strains, probiotics, live biotherapeutics, novel foods, feed additive production and fermentation among...
Adalberto is our Product Managers Genomics & Regulatory Affairs. Adalberto graduated in Medical Biotechnology at the University of Trieste. He specialised in molecular biology and next-generation sequencing during his PhD at the Radboud University in Nijmegen, where he studied the transcriptonal mechanisms of cancer cells. Adalberto is BaseClear’s technical expert on short and long read NGS platforms, including the latest nanopore-based technologies, and how to best use them for specific applications.
Contact Adalberto
